Wealth Enhancement Advisory Services
RLAY icon

Wealth Enhancement Advisory Services’s Relay Therapeutics RLAY Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
54,475
-909
-2% -$13.2K ﹤0.01% 2010
2026
Q1 		$695K Buy
55,384
+7,740
+16% +$69.2K ﹤0.01% 2068
2025
Q4 		$389K Buy
47,644
+497
+1% +$3.55K ﹤0.01% 2688
2025
Q3 		$275K Buy
47,147
+6,164
+15% +$23.5K ﹤0.01% 2873
2025
Q2 		$149K Buy
40,983
+25,511
+165% +$75.9K ﹤0.01% 3070
2025
Q1 		$40.5K Buy
+15,472
New +$60.6K ﹤0.01% 2864

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Wealth Enhancement Advisory Services's RLAY Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Relay Therapeutics (RLAY) stake by 1.6% in Q2 2026, selling an estimated $13.2K and leaving 54,475 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

Wealth Enhancement Advisory Services first reported a position in RLAY in Q1 2025 and has held it in 6 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Wealth Enhancement Advisory Services held 54,475 shares of Relay Therapeutics worth $1.09M as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 909 Relay Therapeutics shares in Q2 2026, an estimated $13.2K.
  • Relay Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2010 holding.
  • Wealth Enhancement Advisory Services first reported a position in Relay Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.